CITIZENS NEWS

A comprehensive look at DMSO's potential in cancer treatment

By ramontomeydw // 2025-04-30

• DMSO is a colorless, odorless liquid with broad medical and industrial uses. Therapeutically, it shows promise in cancer treatment due to its ability to carry substances across cell membranes and reduce oxidative stress.
• Joe B. Floyd, a colon cancer patient, rejected chemotherapy in favor of Dr. E.J. Tucker's DMSO-based therapy. His cancer markers normalized within 18 months, and he remained cancer-free for years.
• In the 1960s, Tucker discovered that DMSO combined with the dye haematoxylon can target cancer cells, causing regression in animal and human cancers (e.g., fibrosarcoma, lymphosarcoma).
• DMSO's anticancer potential stems from its ability to transport agents like haematoxylon which, upon oxidation, produces a compound that negatively impacts cancer cells, ultimately leading to their death. DMSO also enhances drug delivery into cells, complementing traditional therapies.
• Despite evidence of its efficacy, FDA approval for DMSO in cancer treatment faces delays due to safety concerns, politics and economic factors. Advocates argue for broader accessibility given its therapeutic potential.

Dimethyl sulfoxide (DMSO) is a colorless, odorless and slightly oily liquid with a wide range of applications in medicine and industry. Despite its controversial history, DMSO has shown remarkable potential in treating various medical conditions, including cancer, as Dr. Morton Walker elaborates in his book "DMSO: Nature's Healer." The story of Joe B. Floyd, a former Exxon Oil corporate executive, exemplifies the potential of DMSO in cancer treatment. Diagnosed with adenocarcinoma of the colon in 1974, Floyd was advised to undergo chemotherapy after surgery. However, he opted for an alternative treatment based on the research of Dr. E.J. Tucker that included DMSO as a key component. Within eighteen months, Floyd's carcinoembryonic antigen levels dropped from a high of 18 to zero, and he was declared cured. As of 1989, Floyd remained cancer-free, attributing his recovery to Tucker's DMSO-based therapy. Tucker's interest in DMSO as a cancer treatment began in 1966. He discovered that DMSO could effectively dissolve haematoxylon, a dye used to stain tissues, and that the combination had a particular affinity to tumor cells. His experiments with animals showed promising results, with tumors regressing and even disappearing after treatment with the DMSO-haematoxylon solution. Tucker's research extended to human subjects, where he observed significant improvements in patients with various types of cancer. For instance, a woman with inoperable fibrosarcoma experienced tumor regression after receiving DMSO-haematoxylon infusions, eventually leading to the surgical removal of the tumor. The DMSO-haematoxylon solution has shown remarkable efficacy in treating various cancers. In Tucker's studies, the solution was administered intravenously, intra-arterially and topically, depending on the type and location of the cancer. The results were impressive; patients with lymphosarcoma and malignant giant-cell tumors of the bone showed complete regression of their tumors after treatment with the DMSO solution.

The science behind DMSO: How a simple solvent starves cancer cells

The anticancer properties of DMSO are attributed to its ability to act as a carrier for other substances, such as haematoxylon, and its unique interaction with cancer cells. Dr. Thomas D. Rogers' research at the University of North Texas revealed that the DMSO-haematoxylon combination "produces a hematein reaction of oxidation with the tumor cells," rendering the ground substance around the cancer cells inactive. This deprives the cancer cells of nutrition, leading to their death. Furthermore, DMSO's ability to penetrate cellular membranes allows it to deliver anticancer agents directly into cancer cells, enhancing their effectiveness. This property makes DMSO a valuable adjunct in cancer therapy, particularly when combined with treatments like chemotherapy and radiation. However, the use of DMSO in cancer treatment is not without controversy. The Food and Drug Administration's (FDA) reluctance to approve DMSO for cancer is partly due to concerns about its safety and efficacy, as well as political and economic factors. DMSO is a versatile compound with a wide range of potential medical applications. Its ability to penetrate cellular membranes, deliver other substances directly to target tissues and modulate various biological processes makes it a valuable tool in treating cancer and other diseases. While the FDA's approval process for DMSO has been slow and fraught with controversy, the growing body of evidence supporting its efficacy and safety warrants further investigation and consideration. As Walker aptly puts it, "DMSO is a new therapeutic treatment for the people. They deserve access to it." The health and lives of millions of people depend on the timely availability of safe and effective treatments like DMSO. It is time for the medical community and regulatory agencies to recognize the potential of this remarkable compound and ensure its general availability for all who need it. Head over to CancerSolutions.news for more similar stories. Watch this video about the chaga mushroom (Inonotus obliquus), a natural solution for cancer mentioned by Russian novelist Aleksandr Solzhenitsyn in one of his books. This video is from the jroseland channel on Brighteon.com. Sources include: Brighteon.ai Dokumen.pub Brighteon.com

alternative medicine FDA big government healing oncology cures remedies anticancer suppressed discoveries cancer solutions Censored Science goodhealth goodmedicine goodcancer health science medical censorship DMSO dimethyl sulfoxide haematoxylon hematoxylin